GE HealthCare Technologies (GEHC) Non-Current Debt (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Non-Current Debt of $10.1 billion for Q1 2026, up 49.87% on a YoY basis from $6.8 billion in Q1 2025, and up 6.66% quarter-over-quarter from $9.5 billion in Q4 2025.
GE HealthCare Technologies (GEHC) Non-Current Debt (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Non-Current Debt for 5 years, with the latest figure at $10.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt rose 49.87% year-over-year to $10.1 billion; the trailing twelve-month figure through Mar 2026 stood at $10.1 billion (up 49.87% YoY), and the FY2025 full-year result was $9.5 billion, up 27.47% from the prior year.
- Non-Current Debt for Q1 2026 stood at $10.1 billion, up from $9.5 billion in the prior quarter.
- The five-year high for Non-Current Debt was $10.3 billion in Q3 2023, with the low at $6.8 billion in Q1 2025.
- Historically, Non-Current Debt has averaged $8.8 billion across 5 years, with a median of $8.4 billion in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Debt retreated 19.54% — and 2026, when it jumped 49.87%.
- GE HealthCare Technologies' Non-Current Debt stood at $8.2 billion in 2022, then grew by 2.45% to $8.4 billion in 2023, then retreated by 11.7% to $7.4 billion in 2024, then increased by 27.47% to $9.5 billion in 2025, then advanced by 6.66% to $10.1 billion in 2026.
- The last three Non-Current Debt figures came in at $10.1 billion (Q1 2026), $9.5 billion (Q4 2025), and $8.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 6.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.13 Bn |
| Mar 31, 2026 | 10.13 Bn |
| Dec 31, 2025 | 9.50 Bn |
| Dec 31, 2025 | 9.50 Bn |
| Sep 30, 2025 | 8.28 Bn |
| Sep 30, 2025 | 8.28 Bn |
| Jun 30, 2025 | 8.27 Bn |
| Jun 30, 2025 | 8.27 Bn |
| Mar 31, 2025 | 6.76 Bn |
| Mar 31, 2025 | 6.76 Bn |
| Dec 31, 2024 | 7.45 Bn |
| Dec 31, 2024 | 7.45 Bn |
| Sep 30, 2024 | 9.31 Bn |
| Sep 30, 2024 | 9.31 Bn |
| Jun 30, 2024 | 8.23 Bn |
| Jun 30, 2024 | 8.23 Bn |
| Mar 31, 2024 | 8.25 Bn |
| Mar 31, 2024 | 8.25 Bn |
| Dec 31, 2023 | 8.44 Bn |
| Dec 31, 2023 | 8.44 Bn |